Journal of Vascular Surgery

Syndicate content
Journal of Vascular Surgery RSS feed.
Updated: 6 hours 15 min ago

The Influence of Surgical Technique on Device Rotation and Fenestration Alignment in Advanced Endovascular Aneurysm Repair

September 1, 2018 - 00:00
The objective of this study was to assess the interaction between operator insertion technique and iliac artery anatomy on the rotation of fenestrated endovascular devices in an aortoiliac phantom model.

The Influence of Surgical Technique on Device Rotation and Fenestration Alignment in Advanced Endovascular Aneurysm Repair

September 1, 2018 - 00:00
The objective of this study was to assess the interaction between operator insertion technique and iliac artery anatomy on the rotation of fenestrated endovascular devices in an aortoiliac phantom model.

Knowing When Not to Intervene: A Systematic Review of Nonoperative Management in Blunt Thoracic Aortic Injury

September 1, 2018 - 00:00
The role of nonoperative management of blunt traumatic thoracic aortic injury (BTAI) continues to evolve. Our objective was to summarize the growing body of literature on this practice.

Knowing When Not to Intervene: A Systematic Review of Nonoperative Management in Blunt Thoracic Aortic Injury

September 1, 2018 - 00:00
The role of nonoperative management of blunt traumatic thoracic aortic injury (BTAI) continues to evolve. Our objective was to summarize the growing body of literature on this practice.

In Situ Laser Fenestration for Arch Branch Revascularization During Emergent Thoracic Endovascular Aortic Repair: Effective and Durable

September 1, 2018 - 00:00
Retrograde in situ laser fenestration of the left subclavian artery (LSA) or common carotid artery during emergent thoracic endovascular aortic repair (TEVAR) is an innovative method to revascularize arch branches for diverse thoracic aortic diseases. This study provides an update on our expanded experience with extended follow-up to determine the efficiency and durability of this technique.

In Situ Laser Fenestration for Arch Branch Revascularization During Emergent Thoracic Endovascular Aortic Repair: Effective and Durable

September 1, 2018 - 00:00
Retrograde in situ laser fenestration of the left subclavian artery (LSA) or common carotid artery during emergent thoracic endovascular aortic repair (TEVAR) is an innovative method to revascularize arch branches for diverse thoracic aortic diseases. This study provides an update on our expanded experience with extended follow-up to determine the efficiency and durability of this technique.

Endovascular Treatment of Thoracoabdominal Aortic Aneurysms Using Branched and Fenestrated Grafts: Single-Center Experience

September 1, 2018 - 00:00
The objective of this study was to report a Canadian single-center consecutive series of thoracoabdominal aortic aneurysms (TAAAs) treated with custom branched and fenestrated endovascular aneurysm repair (B/F-EVAR).

Endovascular Treatment of Thoracoabdominal Aortic Aneurysms Using Branched and Fenestrated Grafts: Single-Center Experience

September 1, 2018 - 00:00
The objective of this study was to report a Canadian single-center consecutive series of thoracoabdominal aortic aneurysms (TAAAs) treated with custom branched and fenestrated endovascular aneurysm repair (B/F-EVAR).

Role of Drug-Coated Balloons in Femoropopliteal Disease in TransAtlantic Inter-Society Consensus Types C and D Patients

September 1, 2018 - 00:00
This study sought to assess clinical outcomes of a single-center experience following drug-coated balloon (DCB) angioplasty in patients with TransAtlantic Inter-Society Consensus (TASC) II types C and D femoropopliteal peripheral artery disease (PAD).

Role of Drug-Coated Balloons in Femoropopliteal Disease in TransAtlantic Inter-Society Consensus Types C and D Patients

September 1, 2018 - 00:00
This study sought to assess clinical outcomes of a single-center experience following drug-coated balloon (DCB) angioplasty in patients with TransAtlantic Inter-Society Consensus (TASC) II types C and D femoropopliteal peripheral artery disease (PAD).

Status of Cardiac Markers in Patients With Peripheral Arterial Disease and Critical Limb Ischemia

September 1, 2018 - 00:00
Critical limb ischemia (CLI), a severe form of peripheral arterial disease (PAD), is caused by substantial reduction in arterial blood flow to the extremities. Several studies demonstrate significant prevalence of coronary artery disease (CAD) in patients with CLI, leading us to hypothesize that patients with symptomatic PAD will express several diagnostic cardiac markers of CAD in the absence of acute coronary syndrome (ACS).

Status of Cardiac Markers in Patients With Peripheral Arterial Disease and Critical Limb Ischemia

September 1, 2018 - 00:00
Critical limb ischemia (CLI), a severe form of peripheral arterial disease (PAD), is caused by substantial reduction in arterial blood flow to the extremities. Several studies demonstrate significant prevalence of coronary artery disease (CAD) in patients with CLI, leading us to hypothesize that patients with symptomatic PAD will express several diagnostic cardiac markers of CAD in the absence of acute coronary syndrome (ACS).

Geographic Variation in the Rates of Amputations Across Ontario: A Blueprint for Improvement

September 1, 2018 - 00:00
Amputation prevention efforts are often disjointed across health care providers and structured within silos of health care delivery. As a first step toward reducing disparities in limb preservation among peripheral artery disease (PAD) and diabetic patients across Ontario, we sought to compare regional differences in amputation rates.

Geographic Variation in the Rates of Amputations Across Ontario: A Blueprint for Improvement

September 1, 2018 - 00:00
Amputation prevention efforts are often disjointed across health care providers and structured within silos of health care delivery. As a first step toward reducing disparities in limb preservation among peripheral artery disease (PAD) and diabetic patients across Ontario, we sought to compare regional differences in amputation rates.

Frailty Assessment in Older Adults Undergoing Interventions for Peripheral Arterial Disease

September 1, 2018 - 00:00
The objective of this study was to determine the prevalence of frailty in patients with peripheral arterial disease (PAD) and to compare the incremental value of six non-performance-based frailty scales to predict poor outcomes after interventions for PAD.

Frailty Assessment in Older Adults Undergoing Interventions for Peripheral Arterial Disease

September 1, 2018 - 00:00
The objective of this study was to determine the prevalence of frailty in patients with peripheral arterial disease (PAD) and to compare the incremental value of six non-performance-based frailty scales to predict poor outcomes after interventions for PAD.

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses

September 1, 2018 - 00:00
The use of everolimus drug-eluting stents (eDESs) for endovascular bypass graft revision has not yet been reported. The objective of this study was to describe and to compare clinical outcomes of eDESs vs percutaneous cutting balloons (PCBs) vs angioplasty for the treatment of infrainguinal bypass graft stenoses.

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses

September 1, 2018 - 00:00
The use of everolimus drug-eluting stents (eDESs) for endovascular bypass graft revision has not yet been reported. The objective of this study was to describe and to compare clinical outcomes of eDESs vs percutaneous cutting balloons (PCBs) vs angioplasty for the treatment of infrainguinal bypass graft stenoses.

Rivaroxaban Plus Aspirin Versus Standard Dual Antiplatelet Therapy Following Angioplasty for Lower Extremity Peripheral Arterial Disease in Patients With Critical Limb Ischemia and Claudication (RIVAL-PAD): 12-Month Results of a Randomized Trial

September 1, 2018 - 00:00
The objective of this study was to determine the safety and efficacy of a 90-day regimen of rivaroxaban vs clopidogrel in addition to aspirin long term after lower extremity angioplasty.

Rivaroxaban Plus Aspirin Versus Standard Dual Antiplatelet Therapy Following Angioplasty for Lower Extremity Peripheral Arterial Disease in Patients With Critical Limb Ischemia and Claudication (RIVAL-PAD): 12-Month Results of a Randomized Trial

September 1, 2018 - 00:00
The objective of this study was to determine the safety and efficacy of a 90-day regimen of rivaroxaban vs clopidogrel in addition to aspirin long term after lower extremity angioplasty.